Found: 5
Select item for more details and to access through your institution.
Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2417377, doi. 10.1001/jamanetworkopen.2024.17377
- By:
- Publication type:
- Article
Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder.
- Published in:
- Patient Preference & Adherence, 2021, v. 15, p. 1259, doi. 10.2147/PPA.S311674
- By:
- Publication type:
- Article
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 5, p. e219041, doi. 10.1001/jamanetworkopen.2021.9041
- By:
- Publication type:
- Article
Methadone‐related deaths among youth and young adults in Sweden 2006–15.
- Published in:
- Addiction, 2021, v. 116, n. 2, p. 319, doi. 10.1111/add.15152
- By:
- Publication type:
- Article
Increased CD8+ central memory T cells in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2007, v. 13, n. 2, p. 149, doi. 10.1177/1352458506069246
- By:
- Publication type:
- Article